These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 493313)

  • 41. In vitro evaluation of drug-induced toxic effects on the immune system as assessed by proliferative assays and cytokine production.
    Pallardy M; Lebrec H; Blot C; Burleson GR; Bohuon C
    Eur Cytokine Netw; 1991; 2(3):201-6. PubMed ID: 1893072
    [No Abstract]   [Full Text] [Related]  

  • 42. Ultrastructural analysis in preclinical safety evaluation.
    Fagerland JA; Wall HG; Pandher K; LeRoy BE; Gagne GD
    Toxicol Pathol; 2012; 40(2):391-402. PubMed ID: 22215513
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Behavioral tests in acute and chronic toxicity studies.
    Brimblecombe RW
    Pharmacol Ther B; 1979; 5(1-3):413-5. PubMed ID: 493322
    [No Abstract]   [Full Text] [Related]  

  • 44. Reviews on cutting-edge topics in toxicology.
    Bolt HM
    Arch Toxicol; 2014 Dec; 88(12):2097. PubMed ID: 25428173
    [No Abstract]   [Full Text] [Related]  

  • 45. Principles and practices of integrating genotoxicity evaluation into routine toxicology studies: a pharmaceutical industry perspective.
    Krishna G; Urda G; Theiss J
    Environ Mol Mutagen; 1998; 32(2):115-20. PubMed ID: 9776173
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety assessment of drug residues.
    Jackson BA
    J Am Vet Med Assoc; 1980 May; 176(10 Spec No):1141-4. PubMed ID: 6894293
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Introduction to (pre)screening methods.
    Palmer AK
    Reprod Toxicol; 1993; 7 Suppl 1():95-8. PubMed ID: 8400645
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro models for toxicological research and testing.
    Frazier JM
    Toxicol Lett; 1993 May; 68(1-2):73-90. PubMed ID: 8516777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The value of screening methods for the detection of thyroid 'side effects'.
    Sourgens H; Winterhoff H
    Pharmacol Ther B; 1979; 5(1-3):319-23. PubMed ID: 493315
    [No Abstract]   [Full Text] [Related]  

  • 50. [Sensitivity of the primordia of various organs to chemical substances].
    Puchkov VF; Peterka M; Elinek R; Chebotar' NA
    Arkh Anat Gistol Embriol; 1987 Jun; 92(6):13-6. PubMed ID: 3632358
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Testicular and germ cell toxicity: in vitro approaches.
    Lamb JC; Chapin RE
    Reprod Toxicol; 1993; 7 Suppl 1():17-22. PubMed ID: 8400636
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Basic in-vitro toxicity testing on cell cultures].
    Ioniţă I
    Bacteriol Virusol Parazitol Epidemiol; 1995; 40(3-4):181-5. PubMed ID: 8639991
    [No Abstract]   [Full Text] [Related]  

  • 53. [Drug-induced lesions of the endocrine glands].
    Chekman IS; Shcherbak AV; Viktorov AP
    Sov Med; 1987; (7):59-63. PubMed ID: 3317912
    [No Abstract]   [Full Text] [Related]  

  • 54. Whole embryo culture and teratogenesis.
    Steele CE
    Hum Reprod; 1991 Jan; 6(1):144-7. PubMed ID: 1874948
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Environmental factors and nosology of the endocrine system.
    Dacou-Voutetakis C
    Hormones (Athens); 2010; 9(1):7-8. PubMed ID: 20363716
    [No Abstract]   [Full Text] [Related]  

  • 56. Endocrine side-effects of new anticancer therapies: Overall monitoring and conclusions.
    Castinetti F; Albarel F; Archambeaud F; Bertherat J; Bouillet B; Buffier P; Briet C; Cariou B; Caron P; Chabre O; Chanson P; Cortet C; Do Cao C; Drui D; Haissaguerre M; Hescot S; Illouz F; Kuhn E; Lahlou N; Merlen E; Raverot V; Smati S; Verges B; Borson-Chazot F
    Ann Endocrinol (Paris); 2018 Oct; 79(5):591-595. PubMed ID: 30056975
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacologic considerations in the design of toxicology experiments.
    Darby TD
    Clin Toxicol; 1978 Feb; 12(2):229-38. PubMed ID: 648118
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug-induced endocrine and metabolic disorders.
    Ben Salem C; Slim R; Elouni B; Hmouda H; Bouraoui K
    Drug Saf; 2007; 30(8):727-8; author reply 728-9. PubMed ID: 17696585
    [No Abstract]   [Full Text] [Related]  

  • 59. Successful elective surgery in a patient with a positive preoperative cocaine toxicology screen.
    Witt RL; Wilson P
    Ear Nose Throat J; 2010 Feb; 89(2):E14-6. PubMed ID: 20155664
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro methodologies for enhanced toxicity testing.
    DelRaso NJ
    Toxicol Lett; 1993 May; 68(1-2):91-9. PubMed ID: 8516778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.